US Stock MarketDetailed Quotes

Aquestive Therapeutics (AQST)

Watchlist
  • 4.080
  • +0.010+0.25%
Close Apr 24 15:59 ET
  • 4.120
  • +0.040+0.98%
Post 20:01 ET
497.94MMarket Cap-5.23P/E (TTM)

Aquestive Therapeutics (AQST) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-22.61%44.55M
9.67%13.02M
-5.43%12.81M
-50.23%10M
-27.65%8.72M
13.80%57.56M
-10.14%11.87M
4.15%13.54M
51.79%20.1M
8.25%12.05M
Operating revenue
-22.61%44.55M
9.67%13.02M
-5.43%12.81M
-50.23%10M
-27.65%8.72M
13.80%57.56M
-10.14%11.87M
4.15%13.54M
51.79%20.1M
8.25%12.05M
Cost of revenue
3.82%18.56M
29.12%5.84M
1.56%4.51M
0.77%4.56M
-16.79%3.65M
-14.20%17.87M
-3.40%4.52M
-7.52%4.44M
-31.60%4.53M
-7.35%4.39M
Gross profit
-34.52%25.99M
-2.29%7.18M
-8.83%8.3M
-65.05%5.44M
-33.87%5.07M
33.40%39.69M
-13.84%7.35M
10.98%9.11M
135.10%15.57M
19.81%7.66M
Operating expense
37.72%97.04M
72.12%36.02M
13.71%19.78M
8.33%16.81M
47.00%24.43M
57.09%70.46M
68.24%20.93M
64.40%17.4M
43.25%15.52M
51.07%16.62M
Selling and administrative expenses
59.13%79.85M
105.02%32.82M
25.76%15.25M
11.88%12.71M
78.43%19.07M
58.05%50.18M
67.63%16.01M
64.20%12.13M
54.29%11.36M
43.38%10.69M
Research and development costs
-15.23%17.19M
-35.00%3.2M
-14.03%4.53M
-1.37%4.11M
-9.63%5.36M
54.76%20.28M
70.26%4.92M
64.86%5.27M
19.84%4.16M
67.24%5.93M
Operating profit
-130.90%-71.05M
-112.38%-28.84M
-38.47%-11.48M
-20,769.09%-11.37M
-116.20%-19.37M
-103.75%-30.77M
-247.20%-13.58M
-248.76%-8.29M
101.31%55K
-94.51%-8.96M
Net non-operating interest income expense
4.84%-12.73M
13.44%-3.02M
-23.24%-3.97M
22.14%-2.18M
7.90%-3.57M
-251.03%-13.38M
-13.68%-3.49M
-1,693.56%-3.22M
-115.55%-2.8M
-129.72%-3.87M
Non-operating interest income
27.06%4.37M
70.57%1.25M
-68.74%306K
50.25%2.1M
116.72%713K
-78.94%3.44M
344.85%734K
-35.34%979K
981.40%1.4M
-97.73%329K
Non-operating interest expense
1.68%17.1M
1.16%4.27M
1.79%4.27M
1.93%4.28M
1.86%4.28M
125.37%16.82M
30.57%4.22M
219.97%4.2M
193.77%4.2M
182.45%4.2M
Other net income (expense)
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
--0
Income before tax
-89.77%-83.78M
-86.65%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-479.03%-44.15M
-113.10%-17.07M
-429.15%-11.51M
50.16%-2.75M
-259.00%-12.83M
Income tax
0
-105.71%-14K
-113.86%-14K
0
0
0
Net income
-89.83%-83.78M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-460.83%-44.14M
-110.27%-17.06M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
Net income continuous Operations
-89.83%-83.78M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-460.83%-44.14M
-110.27%-17.06M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
Minority interest income
Net income attributable to the parent company
-89.83%-83.78M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-460.83%-44.14M
-110.27%-17.06M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-89.83%-83.78M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-460.83%-44.14M
-110.27%-17.06M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
Basic earnings per share
-52.94%-0.78
-36.84%-0.26
-7.69%-0.14
-366.67%-0.14
-41.18%-0.24
-292.31%-0.51
-41.72%-0.19
-333.33%-0.13
70.00%-0.03
-213.33%-0.17
Diluted earnings per share
-52.94%-0.78
-36.84%-0.26
-7.69%-0.14
-366.67%-0.14
-41.18%-0.24
-292.31%-0.51
-41.72%-0.19
-333.33%-0.13
70.00%-0.03
-254.55%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -22.61%44.55M9.67%13.02M-5.43%12.81M-50.23%10M-27.65%8.72M13.80%57.56M-10.14%11.87M4.15%13.54M51.79%20.1M8.25%12.05M
Operating revenue -22.61%44.55M9.67%13.02M-5.43%12.81M-50.23%10M-27.65%8.72M13.80%57.56M-10.14%11.87M4.15%13.54M51.79%20.1M8.25%12.05M
Cost of revenue 3.82%18.56M29.12%5.84M1.56%4.51M0.77%4.56M-16.79%3.65M-14.20%17.87M-3.40%4.52M-7.52%4.44M-31.60%4.53M-7.35%4.39M
Gross profit -34.52%25.99M-2.29%7.18M-8.83%8.3M-65.05%5.44M-33.87%5.07M33.40%39.69M-13.84%7.35M10.98%9.11M135.10%15.57M19.81%7.66M
Operating expense 37.72%97.04M72.12%36.02M13.71%19.78M8.33%16.81M47.00%24.43M57.09%70.46M68.24%20.93M64.40%17.4M43.25%15.52M51.07%16.62M
Selling and administrative expenses 59.13%79.85M105.02%32.82M25.76%15.25M11.88%12.71M78.43%19.07M58.05%50.18M67.63%16.01M64.20%12.13M54.29%11.36M43.38%10.69M
Research and development costs -15.23%17.19M-35.00%3.2M-14.03%4.53M-1.37%4.11M-9.63%5.36M54.76%20.28M70.26%4.92M64.86%5.27M19.84%4.16M67.24%5.93M
Operating profit -130.90%-71.05M-112.38%-28.84M-38.47%-11.48M-20,769.09%-11.37M-116.20%-19.37M-103.75%-30.77M-247.20%-13.58M-248.76%-8.29M101.31%55K-94.51%-8.96M
Net non-operating interest income expense 4.84%-12.73M13.44%-3.02M-23.24%-3.97M22.14%-2.18M7.90%-3.57M-251.03%-13.38M-13.68%-3.49M-1,693.56%-3.22M-115.55%-2.8M-129.72%-3.87M
Non-operating interest income 27.06%4.37M70.57%1.25M-68.74%306K50.25%2.1M116.72%713K-78.94%3.44M344.85%734K-35.34%979K981.40%1.4M-97.73%329K
Non-operating interest expense 1.68%17.1M1.16%4.27M1.79%4.27M1.93%4.28M1.86%4.28M125.37%16.82M30.57%4.22M219.97%4.2M193.77%4.2M182.45%4.2M
Other net income (expense)
Special income (charges) ----------------------0--0--0--0--0
Income before tax -89.77%-83.78M-86.65%-31.86M-34.21%-15.45M-393.55%-13.55M-78.75%-22.93M-479.03%-44.15M-113.10%-17.07M-429.15%-11.51M50.16%-2.75M-259.00%-12.83M
Income tax 0-105.71%-14K-113.86%-14K000
Net income -89.83%-83.78M-86.81%-31.86M-34.21%-15.45M-393.55%-13.55M-78.75%-22.93M-460.83%-44.14M-110.27%-17.06M-465.55%-11.51M52.61%-2.75M-259.00%-12.83M
Net income continuous Operations -89.83%-83.78M-86.81%-31.86M-34.21%-15.45M-393.55%-13.55M-78.75%-22.93M-460.83%-44.14M-110.27%-17.06M-465.55%-11.51M52.61%-2.75M-259.00%-12.83M
Minority interest income
Net income attributable to the parent company -89.83%-83.78M-86.81%-31.86M-34.21%-15.45M-393.55%-13.55M-78.75%-22.93M-460.83%-44.14M-110.27%-17.06M-465.55%-11.51M52.61%-2.75M-259.00%-12.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -89.83%-83.78M-86.81%-31.86M-34.21%-15.45M-393.55%-13.55M-78.75%-22.93M-460.83%-44.14M-110.27%-17.06M-465.55%-11.51M52.61%-2.75M-259.00%-12.83M
Basic earnings per share -52.94%-0.78-36.84%-0.26-7.69%-0.14-366.67%-0.14-41.18%-0.24-292.31%-0.51-41.72%-0.19-333.33%-0.1370.00%-0.03-213.33%-0.17
Diluted earnings per share -52.94%-0.78-36.84%-0.26-7.69%-0.14-366.67%-0.14-41.18%-0.24-292.31%-0.51-41.72%-0.19-333.33%-0.1370.00%-0.03-254.55%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More